Literature DB >> 16476059

CTLA-4 interacts with STAT5 and inhibits STAT5-mediated transcription.

M Srahna1, L A Van Grunsven, J E Remacle, P Vandenberghe.   

Abstract

Cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152) is a member of the immunoglobulin gene superfamily with strong homology to the receptor CD28 with which it shares the ligands CD80 and CD86. Unlike CD28, a potent costimulator of T-cell responses, CTLA-4 is transiently expressed on the cell surface of activated T cells and appears to operate predominantly as a negative regulator of T-cell proliferation. Signal transduction mechanisms utilized by CTLA-4 remain unclear although several mechanisms have been implicated. In this study, we show that the cytoplasmic domain of CTLA-4, but not of CD28, binds to STAT5 in yeast two-hybrid assay and in coimmunoprecipitation assays. Mutations of Tyr165 and Tyr182 in CTLA-4 did not abrogate the interaction of STAT5 with CTLA-4. Finally, the overexpression of CTLA-4 in Jurkat T cells inhibits STAT-mediated activation of STAT5 responsive elements. These results suggest that CTLA-4 and STAT5 interact in T cells and that this interaction is important for CTLA-4 signalling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476059      PMCID: PMC1782240          DOI: 10.1111/j.1365-2567.2005.02313.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.

Authors:  G J Freeman; D B Lombard; C D Gimmi; S A Brod; K Lee; J C Laning; D A Hafler; M E Dorf; G S Gray; H Reiser
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

2.  CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location.

Authors:  K Harper; C Balzano; E Rouvier; M G Mattéi; M F Luciani; P Golstein
Journal:  J Immunol       Date:  1991-08-01       Impact factor: 5.422

3.  Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.

Authors:  G J Freeman; F Borriello; R J Hodes; H Reiser; K S Hathcock; G Laszlo; A J McKnight; J Kim; L Du; D B Lombard
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

4.  CTLA-4 can function as a negative regulator of T cell activation.

Authors:  T L Walunas; D J Lenschow; C Y Bakker; P S Linsley; G J Freeman; J M Green; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

5.  An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction.

Authors:  H Nakajima; X W Liu; A Wynshaw-Boris; L A Rosenthal; K Imada; D S Finbloom; L Hennighausen; W J Leonard
Journal:  Immunity       Date:  1997-11       Impact factor: 31.745

6.  Expression and functional significance of an additional ligand for CTLA-4.

Authors:  D J Lenschow; G H Su; L A Zuckerman; N Nabavi; C L Jellis; G S Gray; J Miller; J A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

7.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

8.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

9.  Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli.

Authors:  E B Traenckner; H L Pahl; T Henkel; K N Schmidt; S Wilk; P A Baeuerle
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

10.  CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

Authors:  M F Krummel; J P Allison
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  7 in total

1.  Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses.

Authors:  Christine Vogtenhuber; Christoph Bucher; Steven L Highfill; Lisa K Koch; Emily Goren; Angela Panoskaltsis-Mortari; Patricia A Taylor; Michael A Farrar; Bruce R Blazar
Journal:  Blood       Date:  2010-05-04       Impact factor: 22.113

2.  Regulation of human T cell responses by dNP2-ctCTLA-4 inhibits human skin and microvessel graft rejection.

Authors:  Sangho Lim; Nancy C Kirkiles-Smith; Jordan S Pober; Alfred L M Bothwell; Je-Min Choi
Journal:  Biomaterials       Date:  2018-08-21       Impact factor: 12.479

3.  Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma.

Authors:  Begoña Comin-Anduix; Hooman Sazegar; Thinle Chodon; Douglas Matsunaga; Jason Jalil; Erika von Euw; Helena Escuin-Ordinas; Robert Balderas; Bartosz Chmielowski; Jesus Gomez-Navarro; Richard C Koya; Antoni Ribas
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

Review 4.  Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis.

Authors:  Alimuddin Zumla; Martin Rao; Ernest Dodoo; Markus Maeurer
Journal:  BMC Med       Date:  2016-06-15       Impact factor: 8.775

Review 5.  Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer.

Authors:  Hao Zhang; Ziyu Dai; Wantao Wu; Zeyu Wang; Nan Zhang; Liyang Zhang; Wen-Jing Zeng; Zhixiong Liu; Quan Cheng
Journal:  J Exp Clin Cancer Res       Date:  2021-06-04

Review 6.  Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy.

Authors:  Gil-Ran Kim; Je-Min Choi
Journal:  Mol Cells       Date:  2022-07-27       Impact factor: 4.250

7.  Antitumor T-cell Homeostatic Activation Is Uncoupled from Homeostatic Inhibition by Checkpoint Blockade.

Authors:  Netonia Marshall; Keino Hutchinson; Thomas U Marron; Mark Aleynick; Linda Hammerich; Ranjan Upadhyay; Judit Svensson-Arvelund; Brian D Brown; Miriam Merad; Joshua D Brody
Journal:  Cancer Discov       Date:  2019-08-02       Impact factor: 39.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.